FindTrial
Sign In

A medical records based study for laparoscopic-assisted versus open transhitial gastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction

Laparoscopic-assisted versus open transhitial gastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053647
Enrollment
Unknown
Registered
2021-11-26
Start date
2021-11-26
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenocarcinoma of the esophagogastric junction

Interventions

Laparoscopic assisted gastrectomy group:None
Open gastrectomy group:None

Sponsors

The First Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Histologically proven Siewert type II AEG; 2.Surgery via either OTG or LTG with total or proximal gastrectomy, and curative R0 resection with D2 lymphadenectomy; 3.Staging T1-4a, N0-3, M0 (According to the 8th edition of the TNM staging system of the American Joint Committee on Cancer (AJCC); 4.Esophageal invasion <3cm.

Exclusion criteria

Exclusion criteria: 1.Patients with a secondary malignancy within 5 years; 2.American Society of Anesthesiologists physical status score (ASA) > 3; 3.Only underwent palliative resection or combined organ resection; 4.Received preoperative chemotherapy of radiotherapy.

Design outcomes

Primary

MeasureTime frame
Survival;—

Countries

China

Contacts

Public ContactWang Xinxin

The First Medical Center of Chinese PLA General Hospital

301wangxx@sina.com+86 10 66968328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026